ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,118.71
      0.53%
      US Tech 100
      21,284.40
      0.11%
      Dow Jones
      44,565.07
      0.92%
      Brent Oil
      77.36
      -1.24%
      Bitcoin
      103,049.60
      -0.56%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Novacyt (ALNOV) Quote

      Novacyt

      Novacyt (ALNOV)

      EU
      0.595
      -0.015
      (-2.46%)
      Closed January 23 11:30AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.595
      Bid
      0.587
      Ask
      0.595
      Volume
      381,132
      0.575 Day's Range 0.61
      0.4932 52 Week Range 1.59
      Market Cap
      42.023M
      Previous Close
      0.61
      Open
      0.609
      Last Trade
      1
      @
      0.595
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      460,110
      Shares Outstanding
      70,626,248
      Dividend Yield
      -
      PE Ratio
      0.00
      Earnings Per Share (EPS)
      -
      Revenue
      11.58M
      Net Profit
      -28.29M

      About Novacyt

      Sector
      In Vitro,in Vivo Diagnostics
      Industry
      In Vitro,in Vivo Diagnostics
      Website
      www.novacyt.com
      Headquarters
      Velizy-villacoublay, Yvelines, Fra
      Founded
      -
      Novacyt is listed in the In Vitro,in Vivo Diagnostics sector of the Euronext with ticker ALNOV. The last closing price for Novacyt was 0.61 €. Over the last year, Novacyt shares have traded in a share price range of 0.4932 € to 1.59 €.

      Novacyt currently has 70,626,248 shares outstanding. The market capitalization of Novacyt is 43.08 € million.

      Ask ADVFN Intelligence (AI)

      ALNOV Latest News

      More News

      Novacyt S.A. ("Novacyt", the "Company" or the "Group"): DHSC Claim Update – Trial Date Listed

      Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the High Court has notified Novacyt that the hearing of the case...

      January 30 2023
      Business Wire

      Novacyt S.A. ("Novacyt", the "Company" or the "Group") Rapport d’activité pour l'année 2022

      Le chiffre d'affaires et l'EBITDA sont conformes aux prévisions. Concentration sur la stratégie de croissance post-COVID-19 pour devenir un leader mondial du diagnostic clinique dans le domaine...

      January 26 2023
      Business Wire

      Novacyt S.A. ("Novacyt", la "Société" ou le "Groupe"): Départ à la retraite d’un Administrateur non-exécutif

      Regulatory News: Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste international du diagnostic clinique, annonce qu'Edwin Snape a informé le Conseil d'administration qu'il souhaitait...

      December 07 2022
      Business Wire

      Novacyt S.A. ("Novacyt", la "Société" ou le "Groupe") : Approbation du test PCR genesig® COVID-19 3G au Royaume-Uni en vertu de la réglementation CTDA

      Regulatory News: Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste international du diagnostic clinique, annonce l’approbation de son test PCR en temps réel genesig® COVID-19 3G au...

      December 06 2022
      Business Wire

      Novacyt S.A. (« Novacyt », la « Société » ou le « Groupe »): Changement au niveau de la direction

      Regulatory News: Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste international du diagnostic clinique, annonce que David Allmond quitte ses fonctions de Directeur Général (CEO) et de...

      November 10 2022
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.101-14.51149425290.6960.710.5754614270.65087002DE
      40.0040.6768189509310.5910.840.5756892030.69310066DE
      12-0.124-17.24617524340.7190.840.5424601100.66258682DE
      260.0376.630824372760.5581.590.5218468180.94197786DE
      52-0.005-0.8333333333330.61.590.49325358510.88246681DE
      156-2.505-80.80645161293.13.1670.424903801.18179892DE
      2600.3885188.135593220.206513.960.178617750903.16994843DE

      ALNOV - Frequently Asked Questions (FAQ)

      What is the current Novacyt share price?
      The current share price of Novacyt is 0.595 €
      How many Novacyt shares are in issue?
      Novacyt has 70,626,248 shares in issue
      What is the market cap of Novacyt?
      The market capitalisation of Novacyt is EUR 43.08M
      What is the 1 year trading range for Novacyt share price?
      Novacyt has traded in the range of 0.4932 € to 1.59 € during the past year
      What is the reporting currency for Novacyt?
      Novacyt reports financial results in GBP
      What is the latest annual turnover for Novacyt?
      The latest annual turnover of Novacyt is GBP 11.58M
      What is the latest annual profit for Novacyt?
      The latest annual profit of Novacyt is GBP -28.29M
      What is the registered address of Novacyt?
      The registered address for Novacyt is 13 AVENUE MORANE SAULNIER, VELIZY-VILLACOUBLAY, YVELINES, 78140
      What is the Novacyt website address?
      The website address for Novacyt is www.novacyt.com
      Which industry sector does Novacyt operate in?
      Novacyt operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ALNMRNamR SA
      0.48 €
      (118.18%)
      		172.3k
      GNROGeNeuro SA
      0.224 €
      (57.75%)
      		1.93M
      DMSBSDiagnostic Medical Systems
      0.007 €
      (55.56%)
      		108.08k
      FORSEForsee Power SA
      0.736 €
      (20.46%)
      		650.18k
      IVAInventiva
      2.50 €
      (19.05%)
      		226.8k
      MLERHElix Rental Housing Socimi ii SA
      2.00 €
      (-90.00%)
      		1
      ALCYBCybergun
      0.0001 €
      (-50.00%)
      		65.99M
      MLOCTOctopus Biosafety
      0.148 €
      (-35.65%)
      		10.55k
      ALNEVNeovacs
      0.3903 €
      (-21.77%)
      		24.06k
      ALRPDRapid Nutrition
      0.0316 €
      (-18.97%)
      		8.93M
      ATOAtos SE
      0.0021 €
      (0.00%)
      		465.95M
      BCPBanco Comercial Portugues SA
      0.5186 €
      (1.85%)
      		73.43M
      ALCYBCybergun
      0.0001 €
      (-50.00%)
      		65.99M
      ALVERVergnet
      0.0014 €
      (-12.50%)
      		59.46M
      ALMASMastrad
      0.0202 €
      (-3.81%)
      		20.52M

      Discussion

      View Full Feed
      Gmenfan Gmenfan 2 minutes ago
      Senate advances Pete Hegseth as Trump’s defense secretary, despite allegations against him

      https://apnews.com/article/pete-hegseth-defense-secretary-pentagon-trump-confirmation-79d38a3d821eda7e03789e857b417a7f
      vdog1776 vdog1776 2 minutes ago
      Please put in a market sell order!
      VXIT
      xxxx xxxx 2 minutes ago
      Trump signs executive order promoting crypto, paving way for digital asset stockpile
      SHIBUSD
      threebabiesbusy threebabiesbusy 2 minutes ago
      Does anyone know "what's up" with this?
      NLSP
      CommonCents3 CommonCents3 2 minutes ago
      Kinda like you doubted we would ever submit for EMA approval and we would never get published in a peer review journal? Got it. So it's pretty much a sure thing that we submit to the FDA. Hope you keep batting 1.000. Man, ur bad at this. 
      AVXL
      vdog1776 vdog1776 2 minutes ago
      Because according to some people, it’s a scam sell as soon as you can get your money! Please someone put in a market order tomorrow
      VXIT
      Huggy Bear Huggy Bear 2 minutes ago
      Oh I know. But of course folks will go on and on as if it never happened.

      Classic rug pull.
      HMBL
      i_like_bb_stock i_like_bb_stock 3 minutes ago
      nice
      Urocka Urocka 3 minutes ago
      Okay thank you very much for that. I believe they got robbed of a whole facility worth of product not long after that. Yes a new CEO would be good for moral. Still hanging on to some glimmer of hope here...
      PVSP
      SLC-JD SLC-JD 3 minutes ago
      You're absolutely correct, but I'm pretty sure that a former employee/consultant who left on less than great terms won't have the kind of comments that will lead to more investor confidence.

      Proof (one way or the other) will be in the pudding on 3/31 and/or 5/15. Until then, anything
      SHMN
      price_and_volume price_and_volume 3 minutes ago
      But you guys all think the same.

      If you're not selling, why would anyone else?
      VXIT
      packerfan9 packerfan9 4 minutes ago
      Yes. Problem here is. Just ask anyone holding shares. When dilution never ends. It ends up again at .00001 and done. Only ones who made money here. Is if in and out the few days this ever runs. I see all the same as it has been for years. They sell shares not much CBD. The only shares filling buys n
      CBDL
      vdog1776 vdog1776 4 minutes ago
      Yep you’re right he has been taken hostage!
      VXIT
      janice shell janice shell 4 minutes ago
      One can always hold the asparagus spear by its base, and dip it in the Hollandaise.
      LOB LOB 4 minutes ago
      Crazy action yesterday, More to come? Volume is the key. They are trying to get back on Nasdaq.
      SVUHF
      SSKILLZ1 SSKILLZ1 4 minutes ago
      PRGS

      Brought PRGS today, at $54.49 here is what I like.

      Software Stocks Generally get relatively high PE's so to get a software company at about a little over 10x earnings guidance of $5.00-5.12 for FY 25. Seems waaaaaaaaaaaaaaay to cheap to me. I think PRGS deserves a
      price_and_volume price_and_volume 4 minutes ago
      Maybe waiting for JK to be released by HAMAS...

      Surely he's a hostage, otherwise why would he be silent while both companies are delinquent... again...?
      VXIT
      vdog1776 vdog1776 5 minutes ago
      If someone happens to want to put in a market sell order for 20 million they are welcome!!
      VXIT
      tjvs tjvs 5 minutes ago
      Get your self a lawyer your gonna need it .
      TSOI
      prototype_101 prototype_101 5 minutes ago
      Marco said, It will not be revenues that move the stock price in 2025, it will be the deals

      No doubt, and let's not forget that LWLG Perk can solve the long-standing issues of the MRR developments of Intel/Ayars simply by spinning on the Perk to what they have already been developing
      ASM LWLG
      TenKay TenKay 5 minutes ago
      Humbl no longer owns Humbl Financial. Foote pulled the same stunt with Avrio that he did with WSCG…although WSCG was a next level asset strip.
      HMBL
      KCCO7913 KCCO7913 6 minutes ago
      Hm. From their website:

      "From 400 Gb/s optical modulators to advanced optical design for medical products, Sanmina offers a full array of optical, laser and sensor custom manufacturing and collaborative design services — in multiple locations around the world. Our engineers, designers
      LWLG
      barnstormer barnstormer 6 minutes ago
      Mixed indeed. January had been a pretty nice month so far despite my NWBO position being pretty much flat to slightly down. Today it was the winner that gave me a nice positive day on double the normal volume despite my other positions being flat to slightly down. Maybe a sign. I've always felt that
      NWBO
      DiscoverGold DiscoverGold 6 minutes ago
      Crude Oil Tests Key Support Levels Amid Bearish Correction
      By: Bruce Powers | January 23, 2025

      • Crude oil approaches first key support zone at $75.31–$75.54 as selling pressure intensifies, signaling potential for either reversal or deeper bearish correction.
      OILBRENT
      stock_observer_77 stock_observer_77 6 minutes ago
      When she failed 1.75 the second time, it was done

      Your Recent History

      EU
      ALNOV
      Novacyt
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads